Biol stock forecast.

Read Full Company Summary for BIOL here. View Biolase, Inc BIOL investment & stock information. Get the latest Biolase, Inc BIOL detailed stock quotes, stock data, Real-Time ECN, charts, stats and ...BIOLASE Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast BIOLASE stock prices and determine the direction of BIOLASE's future trends based on various well-known forecasting models. However, solely looking at the historical price movement is usually misleading.Request PDF | Levine JM, D'Antonio CM. Forecasting biological invasions with increasing international trade. Conserv Biol ... Key message This study takes stock ...BIOL Stock. USD 0.08 0.0001 0.13%. BIOLASE stock price prediction is an act of determining the future value of BIOLASE shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of BIOLASE's future price could yield a significant profit.

Q4 revenues are expected to be in a range of $12.2 million to $12.5 million, well above consensus expectations of $10.7 million and up approximately 30% sequentially and 45% year-over-year ...

The 1 Wall Street analysts offering BIOLASE stock forecast in the last 6. Forecast target price for 11-06-2022. ... According to our current BIOL stock forecast the value of BIOLASE Inc. BIOL was valued at 161. Shares will drop by. The 4 analysts offering 12-month price forecasts for BIOLASE Inc have a median target of. BIOLASE stock …

BIOL Stock. USD 0.08 0.0001 0.13%. BIOLASE stock price prediction is an act of determining the future value of BIOLASE shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of BIOLASE's future price could yield a significant profit.BIOL Stock Forecast, Price & News (BIOLASE) - MarketBeat WebJan 17, 2023 · BIOLASE (NASDAQ:BIOL) has a market capitalization of $3.32 million and generates $39.19 million in revenue each year. The medical technology company earns $-16,160,000.00 in net income (profit) each year or ($3.57) on an earnings per share basis.Artificial Intelligence Technology Solutions saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 75,400 shares, an increase of 2,692.6% from the October 15th total of 2,700 shares. Based on an average trading volume of 72,060,200 shares, the short-interest ratio is currently 0.0 days.Oct 26, 2023 · Unraveling BIOLASE (BIOL) Stock Predictions for 2022 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing BIOLASE and its promising trajectory, we have meticulously collated insights from various analyst forecasts. In 2023 so far, the iShares Biotechnology ETF (IBB) is down 7.5% while the S&P 500 is up more than 14%—but from 2012 to 2015, IBB beat the S&P 500 by more than 3-to-1. Picking the right biotech ...

Find the latest Sonnet BioTherapeutics Holdings, Inc. (SONN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook ...

Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Evelo Biosciences Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The ...

The 1 Wall Street analysts offering Surface Oncology stock forecast in the last 6 months have average price target of $5.0 with a high forecast of $5.0 and a low forecast of $5.0. The average Surface Oncology stock forecast represents a 367.29% increase from the last price of $1.07000005245209. Stock Price Forecast. According to 3 stock analysts, the average 12-month stock price forecast for BIOLASE stock is $113.33, which predicts an increase …Target values for the price of one BIOLASE share for Aug 2024. The weighted average target price per BIOLASE share in Aug 2024 is: 1.67. In Aug, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 14.327% volatility is expected. Pessimistic target level: 1.51. Optimistic target level: 1.77.Find the latest 2seventy bio, Inc. (TSVT) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Target values for the price of one BIOLASE share for Aug 2024. The weighted average target price per BIOLASE share in Aug 2024 is: 1.67. In Aug, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 14.327% volatility is expected. Pessimistic target level: 1.51. Optimistic target level: 1.77.When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.

Biolase, Inc. (BIOL) stock forecast and price target. Find the latest Biolase, Inc. BIOL analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.2024 STOCK MARKET OUTLOOK. For the third quarter, ended Sept. 30, 2021, BIOL’s net revenue increased 45.8% year-over-year to $9.53 million. The company’s laser system sales increased 64% year-over-year, while its consumables and other revenue increased 21% year-over-year. However, its net loss came in at $3.28 million versus $12,000 in ...allforecast.comOct 24, 2023 · BIOLASE tomorrow. We’ve gathered insights from a variety of expert analysts and amalgamated them to present an integrated daily outlook for BIOLASE shares for the forthcoming month. The nature of short-term forecasts often leads to a decrease in precision, attributed to the myriad of elements at play in the volatile financial markets. BIOLASE stock price predictions for 2022 using artificial intelligence. How much will BIOLASE stock be worth in 2022? ... Detailed predictions for BIOL stock. 2023 ...

NVIDIA Corporation Common Stock. $439.77 -0.64 -0.15%. VFS. VinFast Auto Ltd. Ordinary Shares. $8.11 +0.06 +0.75%. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours ... Find the latest Cabaletta Bio, Inc. (CABA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...

In 2023 so far, the iShares Biotechnology ETF (IBB) is down 7.5% while the S&P 500 is up more than 14%—but from 2012 to 2015, IBB beat the S&P 500 by more than 3-to-1. Picking the right biotech ...16 equities research analysts have issued 12 month price objectives for AbbVie's stock. Their ABBV share price targets range from $150.00 to $196.00. On average, they anticipate the company's stock price to reach $167.94 in the next year. This suggests a possible upside of 17.1% from the stock's current price.What this means: InvestorsObserver gives Biolase Inc (BIOL) an overall rank of 34, which is below average. Biolase Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system.Get The Latest MRNA Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. ... 294th out of 957 stocks. Biological Products, Except Diagnostic Industry. 46th out of 158 stocks. 4.1 Analyst's Opinion. ... View our MRNA earnings forecast.Molecular Biology of Life. An intensive introductory lecture course covering the cell, molecular biology, biochemistry, and the genetics of animals, bacteria, and viruses. This course is comparable to Biology 1101, but places greater emphasis on molecular mechanisms and experimental approaches. BIOL Stock Forecast, Price & News …Sep 20, 2020 · Maybe one or two of three stocks will fail, but those small losses are irrelevant if and when the third stock has a 1,000% return. Here's why Ontrak ( OTRK 3.67%) , Nano-X Imaging ( NNOX 14.20% ... News Ideas Financials Technicals Forecast . BIOL chart. Today −3.48% 5 days −10.47% 1 month −32.73% 6 months −86.88% Year to date −98.37% 1 ... volume and Vumanchu …

Dec 1, 2023 · BIOLASE Stock Forecast 11-30-2023. Forecast target price for 11-30-2023: $ 1.19. Negative dynamics for BIOLASE shares will prevail with possible volatility of 4.961%. Pessimistic target level: 1.17. Optimistic target level: 1.23.

1 equities research analysts have issued 1 year price targets for Cassava Sciences' shares. Their SAVA share price targets range from $11.00 to $124.00. On average, they predict the company's share price to reach $54.33 in the next year. This suggests a possible upside of 154.5% from the stock's current price.

Discover historical prices for BIOL stock on Yahoo Finance. View daily, weekly or monthly format back to when BIOLASE, Inc. stock was issued.Dec 1, 2023 · Full Company Report for BIOL. View Biolase, Inc BIOL investment & stock information. Get the latest Biolase, Inc BIOL detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Request PDF | Levine JM, D'Antonio CM. Forecasting biological invasions with increasing international trade. Conserv Biol ... Key message This study takes stock ...Forecast for July 2025. It is predicted that the price of one BIOLASE share in will be in the range of $0.95 to $1.11. The width of this range will be $0.17 (15.15%). The average price is $1.05, which is $0.07 higher than the average price of the previous month.Their UBX share price targets range from $4.00 to $10.00. On average, they anticipate the company's share price to reach $6.50 in the next twelve months. This suggests a possible upside of 226.6% from the stock's current price. View analysts price targets for UBX or view top-rated stocks among Wall Street analysts.Nov 14, 2023 · BIOLASE stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for BIOLASE analysts is $ 22.25 . Today 200 Day Moving Average is the resistance level ( 17.28 $). Nov 14, 2023 · BIOLASE stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for BIOLASE analysts is $ 22.25 . Today 200 Day Moving Average is the resistance level ( 17.28 $). A high-level overview of BIOLASE, Inc. (BIOL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.According to 5 stock analysts, the average 12-month stock price forecast for Cybin stock is $5.00, which predicts an increase of 959.32%. The lowest target is $3.00 and the highest is $10. On average, analysts rate Cybin stock as a strong buy.

9 Meters Biopharma Stock Forecast, NMTR stock price prediction. Price target in 14 days: 0.0273 USD. The best long-term & short-term 9 Meters Biopharma share price ...4 equities research analysts have issued 1-year price objectives for Fortress Biotech's stock. Their FBIO share price targets range from $15.00 to $75.00. On average, they predict the company's stock price to reach $55.00 in the next year. This suggests a possible upside of 2,582.9% from the stock's current price.The 3 analysts offering 1 year price forecasts for BIOL have a max estimate of — and a min estimate of —. Analyst rating Based on 3 analysts giving stock ratings to BIOL in the past 3 months.For Surface Oncology stock forecast for 2023, 1 predictions are offered for each month of 2023 with average Surface Oncology stock forecast of $1.13, a high forecast of $1.13, and a low forecast of $1.13. The average Surface Oncology stock forecast 2023 represents a 5.47% increase from the last price of $1.07000005245209.Instagram:https://instagram. collectible insurance companiesbest schwab etfheathcare stocksreits vs rental property SYN Stock 12 Months Forecast. $4.00. (292.16% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Synthetic Biologics in the last 3 months. The average price target is $4.00 with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 292.16% change from the last price of $1.02.Biolase, Inc. (BIOL) stock forecast and price target. Find the latest Biolase, Inc. BIOL analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. stock options platformwhere to trade e mini futures Based on 5 Wall Street analysts offering 12 month price targets for Cleanspark in the last 3 months. The average price target is $9.16 with a high forecast of $14.00 and a low forecast of $5.30. The average price target represents a 123.96% change from the last price of $4.09. Highest Price Target $14.00. Average Price Target $9.16.Request PDF | Levine JM, D'Antonio CM. Forecasting biological invasions with increasing international trade. Conserv Biol ... Key message This study takes stock ... mergers and acquisitions news For X4 Pharmaceuticals stock forecast for 2024, 12 predictions are offered for each month of 2024 with average X4 Pharmaceuticals stock forecast of $0.6, a high forecast of $0.75, and a low forecast of $0.5. The average X4 Pharmaceuticals stock forecast 2024 represents a -25.05% decrease from the last price of $0.800599992275238.A high-level overview of BIOLASE, Inc. (BIOL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Oct 15, 2020 · About the BIOLASE, Inc. stock forecast. As of 2023 November 18, Saturday current price of BIOL stock is 1.255$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).